XML 36 R25.htm IDEA: XBRL DOCUMENT
v3.21.2

Business and Liquidity Uncertainties (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2021
Business And Liquidity Uncertainties |
Summary of Components of Marketable Securities | Summary of Components of Marketable Securities
|  | As of September 30, 2021 |
|  | Amortized |  |  | Unrealized |  |  | Fair |
|  | Cost |  |  | Losses |  |  | Value |
U.S. government obligations |  | $ | 324 |  |  | $ | (1 | ) |  | $ | 323 |
Corporate obligations |  |  | 13,912 |  |  |  | (121 | ) |  |  | 13,791 |
|  | $ | 14,236 |  |  | $ | (122 | ) |  | $ | 14,114 |
|  | As of December 31, 2020 |
|  | Amortized |  |  | Unrealized |  |  | Fair |
|  | Cost |  |  | Losses |  |  | Value |
U.S. government obligations |  | $ | 1,021 |  |  | $ | (7 | ) |  | $ | 1,014 |
Corporate obligations |  |  | 629 |  |  |  | (4 | ) |  |  | 625 |
|  | $ | 1,650 |  |  | $ | (11 | ) |  | $ | 1,639 |
Schedule of Components of Inventory | Schedule of Components of Inventory
|  | September 30, |  |  | December 31, |
|  | 2021 |  |  | 2020 |
Diagnostic services testing material |  | $ | 6,203 |  |  | $ | 1,028 |
Raw materials |  |  | 1,464 |  |  |  | 1,404 |
Work in process |  |  | 407 |  |  |  | 437 |
Finished goods |  |  | 436 |  |  |  | 170 |
Inventory, net |  | $ | 8,510 |  |  | $ | 3,039 |
Schedule of Fair Value of Financial Instruments | Schedule of Fair Value of Financial Instruments
|  | As of September 30, 2021 |
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
Marketable debt securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
U.S. government obligations |  | $ | - |  |  | $ | 323 |  |  | $ | - |  |  | $ | 323 |
Corporate obligations |  |  | - |  |  |  | 13,791 |  |  |  | - |  |  |  | 13,791 |
Marketable equity securities |  |  | 214 |  |  |  | - |  |  |  | - |  |  |  | 214 |
|  | $ | 214 |  |  | $ | 14,114 |  |  | $ | - |  |  | $ | 14,328 |
|  | As of December 31, 2020 |
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
Marketable debt securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
U.S. government obligations |  | $ | - |  |  | $ | 1,014 |  |  | $ | - |  |  | $ | 1,014 |
Corporate obligations |  |  | - |  |  |  | 625 |  |  |  | - |  |  |  | 625 |
|  | $ | - |  |  | $ | 1,639 |  |  | $ | - |  |  | $ | 1,639 |
Schedule of Deferred Revenue | The following table disaggregates our deferred revenue by recognition period (in thousands): Schedule of Deferred Revenue
|  | As of September 30, 2021 |  |  | As of December 31, 2020 |
Recognition Period |  |  |  |  |  |  |  |
0-12 Months |  | $ | 1,517 |  |  | $ | 169 |
13-24 Months |  |  | 71 |  |  |  | 84 |
Over 24 Months |  |  | 35 |  |  |  | 78 |
Total |  | $ | 1,623 |  |  | $ | 331 |
Schedule of Disaggregation by Revenue | The following table disaggregates our revenue by revenue source for the three and nine months ended September 30, 2021 and 2020 (in thousands): Schedule of Disaggregation by Revenue
|  | For the three months ended |  |  | For the nine months ended |
Revenue by Customer Type |  | September 30, 2021 |  |  | September 30, 2020 |  |  | September 30, 2021 |  |  | September 30, 2020 |
Contract manufacturing |  | $ | 1,120 |  |  | $ | 3,630 |  |  | $ | 4,069 |  |  | $ | 8,825 |
Retail and others |  |  | 1,210 |  |  |  | 210 |  |  |  | 2,400 |  |  |  | 526 |
Diagnostic services |  |  | 7,142 |  |  |  | - |  |  |  | 27,416 |  |  |  | - |
Total revenue, net |  | $ | 9,472 |  |  | $ | 3,840 |  |  | $ | 33,885 |  |  | $ | 9,351 |

X
- References No definition available. + Details
Name: | PRPH_DisclosureBusinessAndLiquidityUncertaintiesAbstract
Namespace Prefix: | PRPH_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | PRPH_ScheduleOfDeferredRevenueTableTextBlock
Namespace Prefix: | PRPH_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets. + References No definition available. + Details
Name: | us-gaap_MarketableSecuritiesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)(c)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)(b)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)(a)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766 + Details
Name: | us-gaap_ScheduleOfInventoryCurrentTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration